Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Tolmachev V
JSON
CSV
XLSX
TXT
Family name
Tolmachev
Given name
Vladimir
Initials
V
ORCID
ORCID
0000-0002-6122-1734
Affiliations
Department of Immunology, Genetics and Pathology, Uppsala University, 751 23 Uppsala, Sweden. vladimir.tolmachev@igp.uu.se.
4 publications
PubMed
DOI
Crossref
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.
Abouzayed A, Borin J,
Lundmark F
, ..., Chernov V,
Orlova A
Diagnostics (Basel)
13
(9) - [2023-05-02; online 2023-05-02]
PubMed
DOI
Crossref
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.
Lundmark F
, Abouzayed A, Mitran B, ...,
Rosenström U
,
Orlova A
Pharmaceutics
12
(7) - [2020-07-01; online 2020-07-01]
PubMed
DOI
Crossref
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.
Mitran B, Varasteh Z, Abouzayed A, ...,
Orlova A
,
Rosenström U
Cancers (Basel)
11
(9) - [2019-09-14; online 2019-09-14]
PubMed
DOI
Crossref
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.
Abouzayed A, Yim CB, Mitran B, ..., Rosenström U,
Orlova A
Pharmaceutics
11
(7) - [2019-07-23; online 2019-07-23]
SciLifeLab Data Centre
Publications
9.5.1